Efficacy of Subcutaneous Ivermectin With or Without Zinc in COVID-19 Patients

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
To measure the effect of Ivermectin (sub-cutaneous) with or without zinc in treating the COVID-19 patients to clear viral load of SARS-CoV-2 along with reduction in severity of symptoms and length of hospitalization of patients with COVID-19.
Epistemonikos ID: 1c8578ab7867308afbfcedc516a9c178e3b2c6a1
First added on: Jul 16, 2020